Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
3
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
3
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
cancer
clinical trials
europe blog main
europe top stories
ipo
novartis
10x genomics
abbvie
accent therapeutics
aducanumab
allergan
What
fda
3
×
bio
roundup
activity
approvals
august
biogen
biotech
busy
cancer
clamped
covid
days
decisions
delays
developing
devices
drug
drugs
economic
eisai
fast
flags
higher
incidence
including
ipo
isn’t
legacy
lorcaserin
loss
lot
market
marketing
medicine
medicines
new
news
nods
opioid
Language
unset
3
×
Current search:
photo
×
fda
×
national
×
" seattle blog main "
×
unset
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More